Intelligent Bio Solutions Inc., a Delaware-based company, has filed a Form S-8 registration statement with the Securities and Exchange Commission (SEC) on January 12, 2024. The filing is intended to register an additional 1,475,000 shares of common stock for issuance under the company's 2019 Long Term Incentive Plan. This move follows a series of shareholder-approved amendments to the plan, which increased the number of shares authorized for issuance from an initial 25,000 to 1,600,000 shares. The registration incorporates by reference several previously filed documents, including the company's Annual Report and Quarterly Reports. The shares in question have been adjusted to account for a 1-for-20 reverse stock split that took effect on February 9, 2023. Intelligent Bio Solutions Inc. has undertaken to file post-effective amendments during the offering period and to remove from registration any unsold securities at the end of the offering.

Intelligent Bio Solutions Inc., a Delaware-based company, has filed a Form S-8 registration statement with the Securities and Exchange Commission (SEC) on January 12, 2024. The filing is intended to register an additional 1,475,000 shares of common stock for issuance under the company's 2019 Long Term Incentive Plan. This move follows a series of shareholder-approved amendments to the plan, which increased the number of shares authorized for issuance from an initial 25,000 to 1,600,000 shares. The registration incorporates by reference several previously filed documents, including the company's Annual Report and Quarterly Reports. The shares in question have been adjusted to account for a 1-for-20 reverse stock split that took effect on February 9, 2023. Intelligent Bio Solutions Inc. has undertaken to file post-effective amendments during the offering period and to remove from registration any unsold securities at the end of the offering.